Ifp Advisors, Inc United Therapeutics Corp Transaction History

Ifp Advisors, Inc

$2.91 Billion
Q4 2024

A detailed history of Ifp Advisors, Inc transactions in United Therapeutics Corp stock. As of the latest transaction made, Ifp Advisors, Inc holds 855 shares of UTHR stock, worth $260,279. This represents 0.01% of its overall portfolio holdings.

Number of Shares

855

Previous 1,049 18.49%

Holding current value

$260,279

Previous $375,000 19.73%

% of portfolio

0.01%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 04, 2025	SELL	$348.66 - $410.0 $67,640 - $79,540	-194 Reduced 18.49%	855 $301,000
Q3 2024 Feb 04, 2025	BUY	$311.04 - $363.55 $190,356 - $222,492	612 Added 140.05%	1,049 $375,000
Q2 2024 Jul 30, 2024	BUY	$228.26 - $319.04 $7,532 - $10,528	33 Added 8.17%	437 $139,000
Q1 2024 Jul 30, 2024	SELL	$210.76 - $249.51 $27,820 - $32,935	-132 Reduced 24.63%	404 $92,000
Q4 2023 Jan 09, 2024	BUY	$214.88 - $256.94 $26,000 - $31,089	121 Added 29.16%	536 $117,000
Q3 2023 Oct 12, 2023	SELL	$211.82 - $248.24 $25,206 - $29,540	-119 Reduced 22.28%	415 $93,000
Q2 2023 Aug 04, 2023	BUY	$205.19 - $232.99 $63,608 - $72,226	310 Added 138.39%	534 $117,000
Q1 2023 Apr 18, 2023	SELL	$212.99 - $276.17 $71,990 - $93,345	-338 Reduced 60.14%	224 $50,000
Q4 2022 Feb 07, 2023	SELL	$205.95 - $280.43 $35,629 - $48,514	-173 Reduced 23.54%	562 $96,000
Q3 2022 Nov 08, 2022	BUY	$203.3 - $244.17 $52,858 - $63,484	260 Added 54.74%	735 $108,000
Q2 2022 Sep 06, 2022	BUY	$174.81 - $241.14 $83,034 - $114,541	475 New	475 $76,000
Q2 2022 Aug 12, 2022	SELL	$174.81 - $241.14 $83,034 - $114,541	-475 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$166.16 - $213.96 $72,113 - $92,858	434 Added 1058.54%	475 $85,000
Q1 2022 Aug 08, 2022	BUY	$166.16 - $213.96 $498 - $641	3 Added 7.89%	41 $7,000
Q3 2020 Oct 29, 2020	BUY	$99.9 - $121.13 $1,098 - $1,332	11 Added 40.74%	38 $4,000
Q2 2020 Aug 05, 2020	BUY	$92.74 - $125.82 $1,669 - $2,264	18 Added 200.0%	27 $3,000
Q3 2019 Nov 07, 2019	BUY	$74.85 - $85.99 $673 - $773	9 New	9 $1,000
Q1 2019 May 15, 2019	SELL	$107.15 - $126.84 $12,858 - $15,220	-120 Closed	0 $0
Q4 2018 Jan 23, 2019	SELL	$101.4 - $128.73 $7,807 - $9,912	-77 Reduced 39.09%	120 $13,000
Q2 2018 Aug 07, 2018	SELL	$101.14 - $118.31 $7,888 - $9,228	-78 Reduced 28.36%	197 $0
Q1 2018 Jun 03, 2019	BUY	$107.21 - $151.94 $2,573 - $3,646	24 Added 9.56%	275 $41,000
Q1 2018 May 09, 2018	SELL	$107.21 - $151.94 $2,573 - $3,646	-24 Reduced 8.73%	251 $0
Q3 2017 Oct 30, 2017	SELL	$114.6 - $136.81 $12,835 - $15,322	-112 Reduced 28.94%	275 $32,000
Q2 2017 Jun 03, 2019	BUY	N/A	152 Added 64.68%	387 $50,000
Q4 2016 Jun 03, 2019	SELL	N/A	-160 Reduced 40.51%	235 $34,000
Q2 2016 Jun 03, 2019	BUY	N/A	395	395 $42,000

Others Institutions Holding UTHR

# of Institutions

725

Shares Held

61M

Call Options Held

123K

Put Options Held

104K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $13.9B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account